2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow ferumoxides: new trials by email Literature Review of ferumoxides trials Research Report on ferumoxides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients Superparamagnetic Iron Oxide, Technetium99 - Breast Cancer, Sentinel Lymph Node | Phase 2 | Recruiting | Vastra Gotaland Region | 220 | 2023-01-01 | 2024-01-26 |
| Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide Superparamagnetic Iron Oxide - Breast Cancer, Sentinel Lymph Node | Phase 1 / Phase 2 | Completed | Vastra Gotaland Region | 50 | 2021-11-01 | 2025-03-28 |
| Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran Ferucarbotran (Resovist) - Acute Myocardial Infarction | Phase 2 / Phase 3 | Completed | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 20 | 2009-03-01 | 2014-11-07 |
Breast Neoplasms (2)
Vastra Gotaland Region (2) · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) (1)
Sweden (2) · Germany (1)
Roger Olofsson Bagge, MD, PhD (1) · Udo Sechtem, MD (1)